Seventy-eight-year-old John Defazio of Hampton Bays, NY, was recently given a new lease on life, thanks to a new heart valve designed for patients who are not candidates for open heart surgery.
Mr. Defazio suffered from aortic valve stenosis – a severe chronic condition in which the aortic valve does not open properly, hindering the flow of blood from the heart to the rest of the body. As the heart works harder to pump enough blood through the smaller valve opening, the heart weakens, which can cause chest pain, heart palpitations, fatigue, and heart murmur, and may even lead to heart failure.
Traditionally, the primary treatment for aortic stenosis has been surgery. However, until recently, certain patients with severe stenosis were considered too sick for surgery. Therefore, their conditions were considered hopeless.
As Mr. Defazio’s condition worsened this past year, it became apparent that he would not be a candidate for surgery. His cardiologist referred him to Richard Schwartz, DO, Director of Cardiovascular Outreach at NYU Winthrop, who identified Mr. Defazio as an ideal candidate for the new Edwards Sapien Transcathether Heart Valve. This valve is recommended for select patients who are not candidates for open heart surgery and were previously considered untreatable.
On April 27, 2012, a multidisciplinary team of physicians – including Dr. Schwartz, Kevin P. Marzo, MD, Chief of the Division of Cardiology, John A. Goncalves, MD, Chief of the Division of Cardiothoracic Surgery, and Scott L. Schubach, MD, Chairman of the Department of Thoracic & Cardiovascular Surgery – worked collaboratively to replace Mr. Defazio’s valve with the Edwards Sapien Transcathether Heart Valve. This procedure was performed without open heart surgery by inserting the aortic valve via a catheter through an artery in the groin and then advancing it up to the heart. The valve then expanded with a balloon and immediately functioned in place of Mr. Defazio’s own valve.
“As soon as I woke up, I felt so much better. I could breathe easier and my blood pressure improved. To me, it was a miracle,” said Mr. Defazio. “I can’t say enough about my whole team. They gave me a new lease on life.”
NYU Winthrop recently became one of only 70 centers in the United States to offer the Edwards Sapien Transcathether Heart Valve. This revolutionary new technology provides a unique opportunity for heart surgeons and interventional cardiologists at NYU Winthrop to work simultaneously to ensure patients receive the highest level of care.
At NYU Winthrop, high-risk patients can be evaluated by a team of specialists to determine whether or not they are an appropriate candidate for this technology. For more information or to schedule a consultation, call 1-866-WINTHROP.